Reuters logo
BRIEF-Johnson & Johnson says it has ended discussions with Actelion
December 13, 2016 / 11:43 PM / a year ago

BRIEF-Johnson & Johnson says it has ended discussions with Actelion

Dec 13 (Reuters) - Johnson & Johnson :

* Was not able to reach an agreement that it believed would create adequate value for its shareholders

* Johnson & Johnson announces it has ended discussions with Actelion

* Confirmed it has ended discussions with Actelion Pharmaceuticals Ltd regarding a potential transaction Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below